ST Pharm Co.,Ltd. (KOSDAQ: 237690)

ST Pharm Co.,Ltd. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,707,155	1,275,235	1,647,649	2,596,915	1,936,493	555,949
Market Cap Growth	40.60%	-22.60%	-36.55%	34.10%	248.32%	50.51%
Enterprise Value	1,728,179	1,375,695	1,714,024	2,628,966	1,910,417	481,544
Last Close Price	84800.00	67800.00	86887.80	137299.54	102028.58	29291.44
PE Ratio	50.18	65.13	91.54	784.06	-	-
Forward PE	34.23	37.69	67.19	133.19	-	-
PS Ratio	5.83	4.47	6.61	15.68	15.60	5.96
PB Ratio	3.49	3.30	4.83	7.97	6.53	1.83
P/TBV Ratio	4.28	3.44	5.07	8.37	6.79	1.91
P/OCF Ratio	38.03	982.17	234.34	357.22	-	-
EV/Sales Ratio	6.20	4.83	6.87	15.87	15.39	5.16
EV/EBITDA Ratio	33.50	24.33	48.35	131.50	-	-
EV/EBIT Ratio	65.36	41.05	96.02	471.34	-	-
EV/FCF Ratio	-491.17	-	-	-	-	-
Debt / Equity Ratio	0.25	0.50	0.39	0.33	0.43	0.05
Debt / EBITDA Ratio	2.36	3.40	3.79	5.38	-	-
Asset Turnover	0.42	0.46	0.47	0.35	0.32	0.27
Inventory Turnover	1.20	1.53	1.72	1.75	2.45	2.33
Quick Ratio	1.87	2.53	0.82	3.00	10.06	6.21
Current Ratio	4.00	4.16	1.47	4.64	12.66	8.88
Return on Equity (ROE)	6.94%	4.81%	5.25%	1.08%	-4.39%	-5.84%
Return on Assets (ROA)	2.47%	3.36%	2.09%	0.74%	-2.99%	-4.86%
Return on Capital (ROIC)	2.78%	3.97%	2.45%	0.81%	-3.17%	-5.13%
Earnings Yield	1.99%	1.54%	1.09%	0.13%	-0.63%	-3.33%
FCF Yield	-0.21%	-3.29%	-3.24%	-1.71%	-1.96%	-6.61%
Dividend Yield	0.59%	0.74%	-	-	-	-
Payout Ratio	29.04%	48.03%	52.25%	-	-	-
Buyback Yield / Dilution	-1.91%	-	-0.77%	-0.05%	-	-
Total Shareholder Return	-1.32%	0.74%	-0.77%	-0.05%	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.